Clinical Effectiveness of the 0.19-mg Fluocinolone Acetonide (FAc) Intravitreal Implant for Diabetic Macular Edema: Anatomic, Visual and Treatment Burden Outcomes

被引：0
|
作者：
Morozova, Christine [1 ]
Humayun, Lucas [1 ,2 ]
Tabandeh, Homayoun [1 ]
Boyer, David S. [1 ]
Dayani, Pouya N. [1 ,3 ]
Rahhal, Firas M. [1 ,3 ]
机构：
[1] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[2] Duke Univ, Durham, NC USA
[3] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2652
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review (vol 7, pg 293, 2018)
    Fusi-Rubiano, William
    Blow, Rebecca R.
    Lane, Mark
    Morjaria, Rupal
    Denniston, Alastair K.
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (01) : 205 - 205
  • [32] A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes
    Estebainha, Raquel
    Goldhardt, Raquel
    Falcao, Manuel
    CURRENT OPHTHALMOLOGY REPORTS, 2020, 8 (01) : 1 - 10
  • [33] Fluocinolone acetonide (0.19 mg) intravitreal implant reduces treatment burden and improves practice resource utilisation for patients with diabetic macular oedema
    Byun, Matthew
    Osher, James
    Riemann, Christopher D.
    BMJ OPEN OPHTHALMOLOGY, 2020, 5 (01):
  • [34] Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema
    Coney, Joseph M.
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2019, 12 : 161 - 169
  • [35] A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes
    Raquel Estebainha
    Raquel Goldhardt
    Manuel Falcão
    Current Ophthalmology Reports, 2020, 8 : 1 - 10
  • [36] Injectable 0.19 mg fluocinolone acetonide (FAc) intravitreal implant for the treatment of non-infectious uveitic macular edema - a retrospective case study analysis
    Khoramnia, Ramin
    Weber, Lea
    Marx, Stefanie
    Scheuerle, Alexander
    Auffarth, Gerd
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [37] Treatment of Refractory Diabetic Macular Edema with Intravitreal Injection of a Fluocinolone Acetonide Implant
    Rubino, Shaina M.
    Komanski, Chris Bligh
    John, Vishak J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [38] The efficacy and safety outcomes of the 0.19 mg fluocinolone acetonide implant after prior treatment with the 0.7 mg dexamethasone implant in patients with diabetic macular edema
    Singh, P.
    Chedid, A.
    Deuchler, S. K.
    Kohnen, T.
    Mueller, M.
    Koch, F. H.
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2018, 11 : 265 - 269
  • [39] Retinal Morpho-Functional Changes Following 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Chronic Diabetic Macular Edema
    Minnella, Angelo Maria
    Picardi, Stefano Maria
    Maceroni, Martina
    Albanesi, Francesca
    De Siena, Elisa
    Placidi, Giorgio
    Caputo, Carmela Grazia
    De Vico, Umberto
    Rizzo, Stanislao
    Falsini, Benedetto
    ADVANCES IN THERAPY, 2021, 38 (06) : 3143 - 3153
  • [40] Retinal Morpho-Functional Changes Following 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Chronic Diabetic Macular Edema
    Angelo Maria Minnella
    Stefano Maria Picardi
    Martina Maceroni
    Francesca Albanesi
    Elisa De Siena
    Giorgio Placidi
    Carmela Grazia Caputo
    Umberto De Vico
    Stanislao Rizzo
    Benedetto Falsini
    Advances in Therapy, 2021, 38 : 3143 - 3153
12345